ANEST IWATA Corporation Reports Q3 FY2026 Earnings Presentation

Source disclosure: February 10, 2026

ANEST IWATA Corporation [6381.T]

TOKYO — ANEST IWATA Corporation, listed on the Tokyo Stock Exchange under code number 6381, reported its third quarter earnings for the fiscal year ending March 2026 on February 10, 2026. The company, led by Representative Director Eisuke Miyo and Executive Vice President Hitoshi Iwata, did not hold an earnings presentation but provided supplementary materials to accompany the announcement.

For the period from April 1, 2025, to December 31, 2025, ANEST IWATA recorded consolidated sales of ¥39.488 billion, marking a decrease of 1.3% compared to the same period last year. Operating income fell by 18.1%, standing at ¥3.796 billion, while ordinary income decreased by 9.2% to ¥5.190 billion. Net income attributable to shareholders of the parent company also declined by 5.6%, reaching ¥3.376 billion. These figures reflect a challenging operating environment for the company during this reporting period.

In terms of financial position, as of the end of the third quarter of the fiscal year 2026, ANEST IWATA's total assets amounted to ¥69.757 billion, with net assets totaling ¥53.967 billion, resulting in a capital adequacy ratio of 68.0%. This represents slight improvements over the previous year’s totals of ¥69.202 billion in total assets and ¥53.561 billion in net assets, with respective ratios of 67.7%.

Regarding dividend expectations, ANEST IWATA has announced interim dividends of ¥41 per share for the first half of the current fiscal year, bringing the cumulative expected dividend for the entire fiscal year up to ¥83 per share. No revisions have been made to previously disclosed dividend forecasts. For the full fiscal year ending March 2026, the company projects overall sales of ¥58.0 billion, representing a 6.6% increase from the prior fiscal year. However, operating income is forecasted to decline by 6.0% to ¥5.550 billion, with ordinary income also projected to drop by 6.0% to ¥6.710 billion. Net income attributable to shareholders of the parent company is anticipated to be ¥4.150 billion, down 3.0% from the previous year, translating to an estimated earnings per share of ¥104.83.

ANEST IWATA continues to implement its performance-linked stock compensation program "Stock Grant Trust (BBT)" since the fiscal year ended March 2020, which affects the calculation of earnings per share by including shares held by the trust in the average number of outstanding shares during the period. The company emphasizes that forward-looking statements included in their report are based on currently available information and certain assumptions deemed reasonable by management, acknowledging that actual results could differ significantly due to various factors. Investors are advised to refer to additional documentation for further details regarding these projections and their utilization.

Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.